(Q28590580)

31 January 2017

title

Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis (English)

1 reference

31 January 2017

Apolipoprotein E and Apolipoprotein A-1 Knock-Out Mice Readily Develop Amyloid A Protein Amyloidosis (English)

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

18 November 2024

1 reference

GOA release 2020-03-11

Apolipoprotein A-I

1 reference

GOA release 2020-03-11

author name string

R. Elliott-Bryant

1

1 reference

31 January 2017

E. S. Cathcart

2

1 reference

31 January 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9325076

18 November 2024

publication date

1 October 1997

1 reference

31 January 2017

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9325076

full work available at URL

18 November 2024

https://api.elsevier.com/content/article/PII:S009012299794397X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

https://api.elsevier.com/content/article/PII:S009012299794397X?httpAccept=text/plain

18 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Clinical Immunology and Immunopathology

18 November 2024

published in

1 reference

31 January 2017

volume

85

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

104–108

1 reference

31 January 2017

1

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

18 November 2024

2

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

18 November 2024

3

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Is Alzheimer's disease an apolipoprotein E amyloidosis?

18 November 2024

4

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis

18 November 2024

5

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

18 November 2024

6

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

18 November 2024

7

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Characterization of high molecular weight amyloid A proteins

18 November 2024

11

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease

18 November 2024

12

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloids

18 November 2024

13

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques

18 November 2024

18

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

18 November 2024

22

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I

18 November 2024

23

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

18 November 2024

25

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

SECONDARY AMYLOIDOSIS IN LEPROMATOUS LEPROSY. POSSIBLE RELATIONSHIPS OF DIET AND ENVIRONMENT.

18 November 2024

26

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit

18 November 2024

28

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

18 November 2024

29

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

18 November 2024

30

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

18 November 2024

31

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis

18 November 2024

32

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E4 genotype is not a risk factor for systemic AA amyloidosis or familial amyloid polyneuropathy

18 November 2024

33

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Apolipoprotein E genotypes in AA and AL amyloidoses

18 November 2024

34

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene

18 November 2024

35

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4397

18 November 2024

Identifiers

0 references

1 reference